Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Saliva Adseverin,1-Alpha Defensin and sRANKL (Soluble RANKL) Levels In Individuals With Different Periodontal Diseases

NCT06402877 is registered in ClinicalTrials.gov with Izmir Katip Celebi University as lead sponsor.

NCT NCT06402877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06402877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Saliva Adseverin,1-Alpha Defensin and sRANKL (Soluble RANKL) Levels In Individuals With Different Periodontal Diseases
Lead sponsor
Izmir Katip Celebi University
Phase
Observational
Overall status
Completed
Start date
June 26, 2024
Completion date
November 24, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periodontal diseases